跳至主要内容
临床试验/NCT03795155
NCT03795155Unknown不适用

Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI-MSLC)

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年12月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Genomic characters of synchronous lessions in each MSLC patient

研究概览

简要总结

This prospective study is to characterize the genomic landscape and genetic heterogeneity of multiple synchronous lung cancer (MSLC) in correlation with comprehensive clinical, histopathological and medical imaging information, in order to improve disease diagnosis and tailored treatment for MSLC patients.

详细描述

  • To initiate a prospective registry of MSLC patients with high-quality clinical samples and detailed medical data.
  • To define the clonal relationship, genomic landscape and potential driver alterations of MSLC using whole-genome sequencing.
  • To determine the intrapatient and intratumor genetic heterogeneity of MSLC.
  • To correlate molecular features with clinical parameters and patient outcome.
  • To serve as a continuous infrastructure for a large variety of research purposes including: A. Diagnostic research B. Prognostic research C. Biological research D. Interventional trial design testing new therapies in MSLC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Confirmed diagnosis of multiple synchronous lung cancers (MSLCs) without metastatic disease
  • Signed informed consent

排除标准

  • Medical or psychiatric condition that would preclude informed consent
  • History of known high-risk infections
  • With metastatic tumors except lung

结局指标

主要结局

Genomic characters of synchronous lessions in each MSLC patient

时间窗: November 30, 2021

Whole-genome sequencing reveals the mutation, copy number variation and structure variation of MSLCs. We will analysis the genomic characters of synchronous lesions in each MSLC patient.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验